Multiparametric MRI (mpMRI)-ultrasound (US) fusion-guided biopsy may improve prostate cancer (PCa) detection and reduce grade misclassification. We compared PCa detection rates on systematic, MRI-targeted, and combined biopsy with evaluation of important subgroups.